Bausch Health Companies (BHC) Stock Price, Quote, News & History

Q: What sector and industry does Bausch Health Companies (BHC) operate in?

Bausch Health Companies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Comments

Bausch Health Companies (BHC) Stock Price, Quote, News & History

BHCNYSE

Logo brought to you by Benzinga Data

Trade with Public

$5.74

0.152.68%

At close: Jan 30, 4:00 PM EST

$5.75

0.010.17%

After Hours: 6:51 PM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$5.59

Close

$5.74

Volume / Avg.

2.24M / 2.64M

Day Range

$5.55 - $5.74

52 Wk Range

4.25 - 8.69

Market Cap

$2.13B

P/E Ratio

5.76

Dividend Yield

-

Exchange

NYSE

RSI

30

Short Interest

1.41%

Days to Cover

2.22

Recent Bausch Health Companies Inc News

Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Why Are Shares Of Bausch Health Up Today?

Bausch Health shares are trading higher Monday after the company announced it acquired a technology firm through one of its subsidiaries.

Alex Perry

Hedge Fund Billionaire Carl Icahn's Q3: The Activist Goes Defensive, Exits A Troubled Bet, And Loads Up On EchoStar

Carl Icahn's hedge fund Q3 portfolio reshuffle: $9.14B, concentrated, contrarian. Walked away from Bausch Health, added EchoStar.

Surbhi Jain

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.51B

Investing Cash Flow (TTM)

-513.00M

Financing Cash Flow (TTM)

-422.00M

Free Cash Flow (TTM)

1.08B

Capital Expenditure (TTM)

-422.00M

Net Change in Cash (TTM)

571.00M

Analyst Trends and Forecast

1

Dec 25

0

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

1.6

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$21.88B

PE Ratio (TTM)

5.76

PE Ratio (FWD)

1.30

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.21

PB Ratio (TTM)

-

Earnings Yield % (TTM)

17.35%

Earnings Yield % (FWD)

77.17%

EV / EBITDA (TTM)

6.63

Price / EBITDA (TTM)

0.63

Price / Free Cash Flow (TTM)

1.92

Book Value / Share

-$1.52

Company Debt

Total Debt

$21.04B

LT Debt

$20.46B

LT Debt Issuance (TTM)

$10.93B

LT Debt Repayment (TTM)

-$11.25B

Total Cash

$1.31B

Debt to Equity

-

Issuance of Debt (TTM)

-$323.00M

Repayment of Debt (TTM)

-$11.25B

Key Statistics

Open

$5.59

Close

$5.74

Volume / Avg.

2.24M / 2.64M

Day Range

$5.55 - $5.74

52 Wk Range

4.25 - 8.69

Market Cap

$2.13B

P/E Ratio

5.76

Dividend Yield

-

Exchange

NYSE

RSI

30

Short Interest

1.41%

Days to Cover

2.22

About

Sector

Health Care

Industry

Pharmaceuticals

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Bausch Health Companies (BHC) stock?

A

You can purchase shares of Bausch Health Companies (NYSE:BHC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bausch Health Companies (BHC) competitors?

A

Other companies in Bausch Health Companies’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Phibro Animal Health Corp (NASDAQ:PAHC) and ANI Pharmaceuticals Inc (NASDAQ:ANIP).

Q

What is the forecast, or price target, for Bausch Health Companies (BHC) stock?

A

Bausch Health Companies has a consensus price target of $7.43.

Q

What is the current price for Bausch Health Companies (BHC)?

A

The stock price for Bausch Health Companies (NYSE: BHC) is $5.75 last updated January 30, 2026 at 6:51 PM EST.

Q

Does Bausch Health Companies (BHC) pay a dividend?

A

There are no upcoming dividends for Bausch Health Companies.

Q

When is Bausch Health Companies (NYSE:BHC) reporting earnings?

A

Bausch Health Companies does not have any upcoming earnings scheduled.

Q

Is Bausch Health Companies (BHC) going to split?

A

There is no upcoming split for Bausch Health Companies.

Q

What sector and industry does Bausch Health Companies (BHC) operate in?

A

Bausch Health Companies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch

Supernus Pharmaceuticals Inc

NASDAQ:SUPN

$48.16

%

WAVE Life Sciences Ltd

NASDAQ:WVE

$13.02

0.62%

Tarsus Pharmaceuticals Inc

NASDAQ:TARS

$64.54

%

Phibro Animal Health Corp

NASDAQ:PAHC

$40.15

%

ANI Pharmaceuticals Inc

NASDAQ:ANIP

$81.90

0.06%

Ocular Therapeutix Inc

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$5.59

Close

$5.74

Volume / Avg.

2.24M / 2.64M

Day Range

$5.55 - $5.74

52 Wk Range

4.25 - 8.69

Market Cap

$2.13B

P/E Ratio

5.76

Dividend Yield

-

Exchange

NYSE

RSI

30

Short Interest

1.41%

Days to Cover

2.22

Recent Bausch Health Companies Inc News

Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Why Are Shares Of Bausch Health Up Today?

Bausch Health shares are trading higher Monday after the company announced it acquired a technology firm through one of its subsidiaries.

Alex Perry

Hedge Fund Billionaire Carl Icahn's Q3: The Activist Goes Defensive, Exits A Troubled Bet, And Loads Up On EchoStar

Carl Icahn's hedge fund Q3 portfolio reshuffle: $9.14B, concentrated, contrarian. Walked away from Bausch Health, added EchoStar.

Surbhi Jain

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.51B

Investing Cash Flow (TTM)

-513.00M

Financing Cash Flow (TTM)

-422.00M

Free Cash Flow (TTM)

1.08B

Capital Expenditure (TTM)

-422.00M

Net Change in Cash (TTM)

571.00M

Analyst Trends and Forecast

1

Dec 25

0

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

1.6

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$21.88B

PE Ratio (TTM)

5.76

PE Ratio (FWD)

1.30

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.21

PB Ratio (TTM)

-

Earnings Yield % (TTM)

17.35%

Earnings Yield % (FWD)

77.17%

EV / EBITDA (TTM)

6.63

Price / EBITDA (TTM)

0.63

Price / Free Cash Flow (TTM)

1.92

Book Value / Share

-$1.52

Company Debt

Total Debt

$21.04B

LT Debt

$20.46B

LT Debt Issuance (TTM)

$10.93B

LT Debt Repayment (TTM)

-$11.25B

Total Cash

$1.31B

Debt to Equity

-

Issuance of Debt (TTM)

-$323.00M

Repayment of Debt (TTM)

-$11.25B

Key Statistics

Open

$5.59

Close

$5.74

Volume / Avg.

2.24M / 2.64M

Day Range

$5.55 - $5.74

52 Wk Range

4.25 - 8.69

Market Cap

$2.13B

P/E Ratio

5.76

Dividend Yield

-

Exchange

NYSE

RSI

30

Short Interest

1.41%

Days to Cover

2.22

About

Sector

Health Care

Industry

Pharmaceuticals

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry